Dallas Cowboys owner Jerry Jones reveals PD-1 therapy saved his life after a 2010 stage 4 melanoma diagnosis and now has 'no ...

Q2 2025 Management View Jennifer S. Buell, President and CEO, stated that MiNK continues to be "the most clinically advanced company, industrializing off-the-shelf, invariant natural killer T cells." ...

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

MiNK Therapeutics(NASDAQ:INKT) reported its fiscal second quarter ended June 30, 2025, on Aug. 14, 2025, posting a $4.2 million net loss and announcing a $13 million equity raise after quarter-end, ...

Superior double-stranded DNA (dsDNA) recovery rates versus other technologies, reducing sequencing requirements by 10- to 100-fold to achieve ultrasensitive detection levels and enabling a ...

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise-and induced great disappointment.

The Breast Cancer Research Foundation, or BCRF, has named Ulta Beauty chief executive officer Kecia Steelman to its board.

Dupilumab may provide a nonsteroidal option for managing cancer therapy-related skin toxicities, according to a study.

Dallas Cowboys owner Jerry Jones speaks at a press conference announcing the retirement of offensive lineman Zack Martin at ...

Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.